Opendata, web and dolomites

ViaOne

A MINIMALLY INVASIVE NEEDLE FREE DEVICE TO SAFELY ACCESS THE PERICARDIUM SPACE

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ViaOne project word cloud

Explore the words cloud of the ViaOne project. It provides you a very rough idea of what is the project "ViaOne" about.

price    pericardium    space    area    structured    af    30    performed    feasibility    techniques    pericardial    safe    11m    il2018    commercialize    clinical    device    ablation    epiviasystem    variety    cardiovascular    arrhythmia    sme    2021    avoiding    market    patients    outcomes    secure    penetration    heart    fibrillation    free    opportunity    treatment    complications    invasive    surgery    patient    24m    600m    epicardial    commercial    confident    cardiac    business    250    tools    mapping       additional    reduce    fact    disorders    ablations    atrial    ensures    5m    puncture    successful    130    release    geometrically    people    healthcare    acute    optimize    employs    marketable    pct    bleeding    first    medical    workspace    needles    deaths    big    equivalent    needle    tamponade    expertise    competitive    skill    procedure    financial    constant    pathological    050670    2016    representing    pathologies    requiring    manner    failed    catheters    thread    electrohpysiological    motion   

Project "ViaOne" data sheet

The following table provides information about the project.

Coordinator
CARDIOVIA LTD. 

Organization address
address: WADI EL HAJ 13
city: NAZARETH
postcode: 1600101
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiovia.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIOVIA LTD. IL (NAZARETH) coordinator 50˙000.00

Map

 Project objective

2.5M patients per year in the US and the EU require pericardial space access as the result of a variety of pathological conditions. Atrial Fibrillation (AF) is the most common condition requiring pericardial access, in fact, AF affected 24M people in the US and 11M in the EU (2016). In current epicardial access techniques (using needles), complications can reach 4.5-30% (representing a Ëž€600M/year increase in costs for healthcare systems) and includes heart puncture, cardiac tamponade and pericardial bleeding, which can result in an increase in patient deaths. The use of a needle in the heart area, which is in constant motion, requires a high level of skill and expertise during surgery. EpiVIASYSTEM is the first device (PCT /IL2018 /050670) to ensure pericardial access in a confident, safe, needle-free manner avoiding complications during penetration of the pericardium. The device employs a unique geometrically structured thread that ensures a secure workspace for the use of additional cardiovascular devices, such as mapping and ablation catheters for treatment of arrhythmia disorders. Its design will ensure a competitive price of €250/procedure when compared with €130 for the equivalent tools used in invasive non-electrohpysiological procedures. EpiVIASYSTEM is expected to improve clinical outcomes of patients and reduce costs associated with failed ablations associated with the needle use by €600M/year. The increased growth of cardiac pathologies and the 2.5M of patients/year that require pericardial access represent a big business opportunity for the EpiVIASYSTEM and will favour its successful market uptake. EpiVIASYSTEM´s main objective is to optimize, scale-up and commercialize a marketable medical device in both the EU and the US by 2021. For that, a feasibility study will be performed during SME Phase 1 to evaluate any technical, commercial and/or financial issues and ensure the successful release of the EpiVIASYSTEM into the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VIAONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VIAONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More